Development and exploration of an AI model to classify "schizophrenia with signs of relapse" and "schizophrenia with no signs of relapse" based on free conversations with medical staff

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030220320

Enrollment

100

Registered

2022-09-03

Start date

2022-09-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Outpatient 2)Between 18 and 65 years of age at the time of consent and diagnosed with schizophrenia according to the DSM-5. 3)Who can obtain written consent from the person 4)Who speak Japanese as his/her mother tongue and able to have an interview (conversation with doctors and medical staff)

Exclusion criteria

Exclusion criteria: 1)Who has been judged by a doctor to have difficulty in having conversation due to deafness, dysarthria, aphasia, etc. 2)Who has been diagnosed of having a pyschiatric disorder such as depression 3)Who has been diagnosed of a dementia or judged to have cognitive dysfunction due to neurological diseases (epilepsy, stroke, etc.) 4)Who has been judged by a doctor not to be suitable for this trial by any reasons

Design outcomes

Primary

Measure	Time frame
Development and exploration of an following AI model based on free conversations with medical staff *to classify the signs of relapse for schizophrenic patient	—

Contacts

Public ContactIrisuna Hiroki

FRONTEO Inc.

hiroki_irisuna@fronteo.com+81-80-4865-1308

Outcome results